Whereas EZH2 nuclear expression was negative in the normal pancreatic ductal cells, EZH2 expression in IPMN lesions increased during IPMN progression, particularly from borderline atypia to invasive carcinoma (Figures 4a and b). This evidence concerns the gene EZH2 and pancreatic intraductal papillary-mucinous neoplasm.